Transparent Coverage of Clinical Trials and Research | TrialSite News

Weekly Roundup

Podcast

Top News Stories

Is Confidence in AZD1222 Waning Among the Drug Development Community?

Is Confidence in AZD1222 Waning Among the Drug Development Community?

November 26, 2020

Icahn School of Medicine Cardiovascular Regenerative Therapy Investigator Receives $2.9m to Investigate Stem Cell Regenerative Powers

Icahn School of Medicine Cardiovascular Regenerative Therapy Investigator Receives $2.9m to Investigate Stem Cell Regenerative Powers

November 26, 2020

Icahn School of Medicine at Mount Sinai Drives Collaborative Investigation into use of Nintedanib in COVID-19 Patients with Fibrosing ILD

Icahn School of Medicine at Mount Sinai Drives Collaborative Investigation into use of Nintedanib in COVID-19 Patients with Fibrosing ILD

November 26, 2020

University of Chicago & University of Illinois at Chicago Receive $2m as Part of RADx Initiative Focusing on COVID-19 in Underserved Communities

University of Chicago & University of Illinois at Chicago Receive $2m as Part of RADx Initiative Focusing on COVID-19 in Underserved Communities

November 26, 2020

Cincinnati Children’s Seeks Volunteers for AstraZeneca COVID-19 Vaccine Trial

Cincinnati Children’s Seeks Volunteers for AstraZeneca COVID-19 Vaccine Trial

November 25, 2020

GC Pharma Gets Additional Nod for COVID-19 Plasma Therapy

GC Pharma Gets Additional Nod for COVID-19 Plasma Therapy

November 25, 2020

Digital Media

Clinical Trials and Research News Weekly Roundup | I-MASK+: Ivermectin Key For Early Treatment

Clinical Trials and Research News Weekly Roundup | I-MASK+: Ivermectin Key For Early Treatment

November 16, 2020

Clinical Trials and Research News Weekly Roundup | Treat COVID-19 Patients Early Antiviral Cocktail?

Clinical Trials and Research News Weekly Roundup | Treat COVID-19 Patients Early Antiviral Cocktail?

November 2, 2020

TSN News

ICON Study Evidencing Efficacy of Ivermectin Against COVID-19 Published in Peer Review Journal Chest

October 13, 2020

Dhaka Medical College Shares Results of Randomized Controlled Trial: Ivermectin & Doxycycline Benefits Patients with Mild to Moderate COVID-19

Dhaka Medical College Shares Results of Randomized Controlled Trial: Ivermectin & Doxycycline Benefits Patients with Mild to Moderate COVID-19

October 11, 2020

A Clinical Trials Convoy: Here Comes the Mobile Clinics to Challenged Communities for COVID-19 Clinical Trials

A Clinical Trials Convoy: Here Comes the Mobile Clinics to Challenged Communities for COVID-19 Clinical Trials

October 4, 2020

Trial Watch

Mumbai Hospital-led Phase 3 Clinical Trial Reveals the Efficacy of Favipiravir Targeting Mild to Moderate COVID-19 Patients in India

Mumbai Hospital-led Phase 3 Clinical Trial Reveals the Efficacy of Favipiravir Targeting Mild to Moderate COVID-19 Patients in India

November 24, 2020

The COVAS Tool: Kaiser Permanente Southern California Develops Tool to Predict Outcomes for COVID-19 in Emergency Dept. Setting

The COVAS Tool: Kaiser Permanente Southern California Develops Tool to Predict Outcomes for COVID-19 in Emergency Dept. Setting

November 22, 2020

Kintara Therapeutics Presents Interim Data from Two Phase 2 Trials of VAL-083 for the Treatment of Glioblastoma Multiforme

Kintara Therapeutics Presents Interim Data from Two Phase 2 Trials of VAL-083 for the Treatment of Glioblastoma Multiforme

November 20, 2020

uniQure Reports Positive Top-Line Data from HOPE-B Trial of Etranacogene Dezaparvovec Gene Therapy for Hemophilia B

uniQure Reports Positive Top-Line Data from HOPE-B Trial of Etranacogene Dezaparvovec Gene Therapy for Hemophilia B

November 20, 2020

Zai Labs, Five Prime Therapeutics Announce Data from Phase 2 FIGHT Trial of Bemarituzumab in 1st Line Gastric Cancer

Zai Labs, Five Prime Therapeutics Announce Data from Phase 2 FIGHT Trial of Bemarituzumab in 1st Line Gastric Cancer

November 20, 2020

Final Data Reported from Urogen’s OPTIMA II Trial Assessing UGN-102 (Mitomycin) Intravesical Solution for Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer

Final Data Reported from Urogen’s OPTIMA II Trial Assessing UGN-102 (Mitomycin) Intravesical Solution for Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer

November 20, 2020

Site Watch

Seek Diversity in COVID-19 Vaccine Trial—Call University of Maryland School of Medicine

Seek Diversity in COVID-19 Vaccine Trial—Call University of Maryland School of Medicine

November 5, 2020

UNC’s Baric Lab Key Contributor to Now Approved Remdesivir (Veklury®): Top Experts in Coronaviruses

UNC’s Baric Lab Key Contributor to Now Approved Remdesivir (Veklury®): Top Experts in Coronaviruses

November 5, 2020

San Antonio Military-based Trial Site Organizations Enrolling Participants for AstraZeneca COVID-19 Vaccine Trial

San Antonio Military-based Trial Site Organizations Enrolling Participants for AstraZeneca COVID-19 Vaccine Trial

November 5, 2020

University of Kansas Medical Center Becomes Hub for American Lung Association Research COVID-19-based Studies

University of Kansas Medical Center Becomes Hub for American Lung Association Research COVID-19-based Studies

November 2, 2020

Wake Forest Baptist the First Health System to Enroll Patients in the Adaptive I-SPY COVID-19 Trial

Wake Forest Baptist the First Health System to Enroll Patients in the Adaptive I-SPY COVID-19 Trial

October 29, 2020

Small Town Playing Big Role in COVID-19 Vaccine Research

Small Town Playing Big Role in COVID-19 Vaccine Research

October 26, 2020

Investor Watch

University of New Mexico First to Treat COVID-19 Acute Kidney Care Patients with Investigational Regenerative Therapy Called SB-101

University of New Mexico First to Treat COVID-19 Acute Kidney Care Patients with Investigational Regenerative Therapy Called SB-101

November 25, 2020

Mekonos Raises $4.6M for its Gene Engineering Platform

Mekonos Raises $4.6M for its Gene Engineering Platform

November 24, 2020

Venture Capital Firm Moves Deeper Into Life Science-Based R&D Innovation with Harvard’s Wyss Institute Financing

Venture Capital Firm Moves Deeper Into Life Science-Based R&D Innovation with Harvard’s Wyss Institute Financing

November 21, 2020

St. Antonius Hospital-based COVID-19 Home Monitoring Program Leads InvestorWatch to Look at Dutch Startup Luscii

St. Antonius Hospital-based COVID-19 Home Monitoring Program Leads InvestorWatch to Look at Dutch Startup Luscii

November 21, 2020

Medable Raises $91 million in Series C Round While Claiming Existing Customers Recruit Patients 3X Faster: Unprecedented if Accurate

Medable Raises $91 million in Series C Round While Claiming Existing Customers Recruit Patients 3X Faster: Unprecedented if Accurate

November 21, 2020

Imago Biosciences Closes $80M Series C to Advance Lead Candidate for Myeloproliferative Neoplasms Through Phase 3 Trials

Imago Biosciences Closes $80M Series C to Advance Lead Candidate for Myeloproliferative Neoplasms Through Phase 3 Trials

November 20, 2020

Pharma Watch

Pfizer Announces FDA Priority Review; EMA Acceptance of Regulatory Submission for Abrocitinib in Patients Over 12 Years of Age with Moderate to Severe Atopic Dermatitis

Pfizer Announces FDA Priority Review; EMA Acceptance of Regulatory Submission for Abrocitinib in Patients Over 12 Years of Age with Moderate to Severe Atopic Dermatitis

October 29, 2020

Lilly on the Verge of COVID-19 Monoclonal Antibody EUA Approval First for High Risk Patients with Recent Mild-to-Moderate COVID-19 Diagnosis

Lilly on the Verge of COVID-19 Monoclonal Antibody EUA Approval First for High Risk Patients with Recent Mild-to-Moderate COVID-19 Diagnosis

October 9, 2020

Regeneron Submits Request for FDA EUA for REGN-COV2 in Head to Head Competition with Eli Lilly

Regeneron Submits Request for FDA EUA for REGN-COV2 in Head to Head Competition with Eli Lilly

October 9, 2020

Novavax Taps into the $1.6b in U.S. Fed Award to Fund Phase 3 Clinical Trial in the UK in Pursuit of Euro Filing

Novavax Taps into the $1.6b in U.S. Fed Award to Fund Phase 3 Clinical Trial in the UK in Pursuit of Euro Filing

September 28, 2020

Novartis Moves to be on the ‘Right Side’ of History, Will Other Big Pharma Follow?

Novartis Moves to be on the ‘Right Side’ of History, Will Other Big Pharma Follow?

July 25, 2020

COVID-19 Vaccine INO-4800 Demonstrates Neutralizing Antibody and T-Cell Immune Responses in Preclinical Models

COVID-19 Vaccine INO-4800 Demonstrates Neutralizing Antibody and T-Cell Immune Responses in Preclinical Models

May 22, 2020

Price Watch

Lilly Inks Deal Worth up to $12.5 Billion with Feds for its Monoclonal Antibody — $12,500 per dose for up to 680K Doses

Lilly Inks Deal Worth up to $12.5 Billion with Feds for its Monoclonal Antibody — $12,500 per dose for up to 680K Doses

October 29, 2020

Sao Paulo State Seeking ANVISA Greenlight for CoronaVac Registration: Buys 46m at $1.95 per Dose

Sao Paulo State Seeking ANVISA Greenlight for CoronaVac Registration: Buys 46m at $1.95 per Dose

October 4, 2020

Are Drug Makers Gouging the American Public with Astronomical Prices? Some in Congress Believe So

Are Drug Makers Gouging the American Public with Astronomical Prices? Some in Congress Believe So

October 2, 2020

Favipiravir Sales Skyrocket in India Targeting Mild COVID-19 Cases

Favipiravir Sales Skyrocket in India Targeting Mild COVID-19 Cases

September 30, 2020

Errant Gene Therapeutics (“EGT”) asks European Authorities to Re-examine the Approval Process of Zynteglo, While US Litigation Moves Forward

Errant Gene Therapeutics (“EGT”) asks European Authorities to Re-examine the Approval Process of Zynteglo, While US Litigation Moves Forward

September 28, 2020

Chief of World’s Busiest Vaccine Manufacturer: The USA & China are ‘Crazy’ for Shunning COVAX Alliance

Chief of World’s Busiest Vaccine Manufacturer: The USA & China are ‘Crazy’ for Shunning COVAX Alliance

September 28, 2020

Popular Posts

24/7 News Feed

Pin It on Pinterest